Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Cyclerion Therapeutics Inc CYCN

As of November 19, 1996, Cycle-Sat Inc was acquired by Vyvx, LLC.

Current News (NDAQ:CYCN)

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cyclerion Therapeutics, Inc. (Nasdaq - CYCN), National Storage Affiliates (NYSE - NSA), Urgent.ly, Inc. (OTC Markets - ULYX), UniFirst Corporation (NYSE - UNF)

GlobeNewswire 1 day ago

Halper Sadeh LLC is Investigating Whether SLNO, FORA, MKC, CYCN are Obtaining Fair Deals for their Shareholders

GlobeNewswire 3 days ago

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-CYCN, FORA, SLNO, and MKC

GlobeNewswire 3 days ago

Halper Sadeh LLC is Investigating Whether UNF, CYCN, NSA, ULYX are Obtaining Fair Deals for their Shareholders

GlobeNewswire 7 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cyclerion Therapeutics, Inc. (Nasdaq - CYCN), National Storage Affiliates (NYSE - NSA), Urgent.ly, Inc. (OTC Markets - ULYX), UniFirst Corporation (NYSE - UNF)

GlobeNewswire 8 days ago

CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders

Business Wire 8 days ago

Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement

Business Wire 9 days ago

Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board

GlobeNewswire February 17, 2026

Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression

GlobeNewswire January 5, 2026

Opinion & Analysis (NDAQ:CYCN)

No current opinion is available.

Bullboard Posts (NDAQ:CYCN)

Thanks for the info Bob

I just sold made a good profit for one day
Bullhunk - 9 days ago

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - January 6, 2026

Using technical analysis for this stock.

It is starting to climb up from its low prices per share,so good luck to all of you guys
coolfooldumbguy - September 24, 2025

Buy buddy buy because it's taking off this morning.

And furthermore you guys will be left behind,so there.
coolfooldumbguy - February 3, 2025

This stock is a good buy for me

At these low price per share levels and it is a good company with a big future ahead of it,so that it was time for me to be getting on...
coolfooldumbguy - January 31, 2025

Cyclerion Therapeutics, Inc. (CYCN): Navigating the Challeng

http://beyondspx.com/2024/08/01/cyclerion-therapeutics-inc-cycn-navigating-the-challenges-of-a-shifting-biotech-landscape/
MikeTester - August 1, 2024